Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06222164

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

LabPMM

San Diego, California, 92121, United States

Location status: Recruiting

Location contact

Andrew Schut

CONTACT

[email protected]

858-224-6600

Jordan Thornes

PRINCIPAL_INVESTIGATOR

About this study

Residual specimen/sample collection study where peripheral blood (PB), bone marrow (BM), genomic (gDNA), and/or formalin-fixed paraffin-embedded tissue (FFPE) specimens/samples are obtained from patient samples sent to LabPMM, LLC for clinical testing. Samples may be used for Clinical Research at LabPMM, LLC or at partner institutions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
  • Donor Age ≥ 18 years

Exclusion criteria

  • Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
  • The specimens/samples have previously been enrolled in a clinical study

Treatment and study plan

Primary outcomes

  1. Enrollment

    Time frame: 3 years

    N=2000

Study contacts

Contact information is provided by the study sponsor or research team.

Andrew Schut

CONTACT

[email protected]

+1 858.224.6600

Sponsors and collaborators

Lead sponsor

Invivoscribe, Inc.

Industry

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Jan 24, 2024
Registry last updated
May 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.